Reactive Dry Powdered Hemostatic Materials Comprising a Protein and a Multifunctionalized Modified Polyethylene Glycol Based Crosslinking Agent
Copyright © Targeted News Service 2024
2024-11-26
ALEXANDRIA, Virginia, Nov. 26 -- DAVOL INC., Warwick, Rhode Island has been assigned a patent (No. US 12151045 B2, initially filed Dec. 27, 2021) developed by Keith Greenawalt, Milton, Massachusetts, and Frederick H. Strickler, Jr., Boston, Massachusetts, for "Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent." . . .